Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03630185
Other study ID # HSC-MS-17-0015
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 25, 2017
Est. completion date November 30, 2018

Study information

Verified date February 2020
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to assess the efficacy of custom-manufactured compression hosiery (also known as compression stockings) compared to similar off-the-rack (OTR) compression stockings.


Recruitment information / eligibility

Status Terminated
Enrollment 8
Est. completion date November 30, 2018
Est. primary completion date November 30, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Ability to comprehend and sign an informed consent and complete study questionnaires

- Patient is participating in usual work and home activities with no changes anticipated for the duration of the study

- The use of compression stocking is prescribed in accordance with the usual practice and management of venous disorders

- The patient will confirm they are willing to pay for the compression stockings.

Exclusion Criteria:

- The patient has a known allergy to any component of the stocking (latex, etc)

- The patient has non-venous source of pain in either leg that could, in the opinion of the investigator, confound the results of the study i.e.Neuropathy, Arterial insufficiency, Diabetes

- The patient is confined to bed

- The patient has uncontrolled Congestive Heart Failure

- The patient has acute dermatitis

- The patient has weeping dermatosis

- Patients with venous ulcers will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Custom-manufactured compression hosiery (Isobar)
The custom-fitted garment is manufactured specifically for each patient based on measurements taken with a 3-dimensional volumetric laser scan of the extremity, and can be sized individually to each limb.
Off-the-rack stockings (Sigvaris)
Currently available off-the-rack compression hosiery are manufactured in eight fixed sizes (S-XLFC) that cannot be varied in size over their length to accommodate unusual anatomic patterns (eg., small ankle with large calf or vice versa) and may not achieve a comfortable fit that meets the compression goal over a uniform distribution of the limb.

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Management Experienced During Their Postoperative Care as Assessed by Five-point Satisfaction Scale Five-point satisfaction scale consists of patients rating their overall postoperative pain management experience using a 5-point rating system. The scale ranges from 1 to 5, with 1 being "extremely dissatisfied", 2 "somewhat dissatisfied", 3 "Neutral/Neither satisfied nor dissatisfied", 4 "somewhat satisfied" and 5 "extremely satisfied" with their postoperative pain care. 6 weeks
Primary Pain Management Experienced During Their Postoperative Care as Assessed by Five-point Satisfaction Scale Five-point satisfaction scale consists of patients rating their overall postoperative pain management experience using a 5-point rating system. The scale ranges from 1 to 5, with 1 being "extremely dissatisfied", 2 "somewhat dissatisfied", 3 "Neutral/Neither satisfied nor dissatisfied", 4 "somewhat satisfied" and 5 "extremely satisfied" with their postoperative pain care. 90 days
Primary Pain Management Experienced During Their Postoperative Care as Assessed by Five-point Satisfaction Scale Five-point satisfaction scale consists of patients rating their overall postoperative pain management experience using a 5-point rating system. The scale ranges from 1 to 5, with 1 being "extremely dissatisfied", 2 "somewhat dissatisfied", 3 "Neutral/Neither satisfied nor dissatisfied", 4 "somewhat satisfied" and 5 "extremely satisfied" with their postoperative pain care. 6 months
Primary Pain as Assessed by Brief Pain Inventory The Brief Pain Inventory is a medical questionnaire used to measure pain, developed by the Pain Research Group of the World Health Organization Collaborating Center for Symptom Evaluation in Cancer Care.
The score is an average of seven questions about pain interference in life. The score scale is from 0 to 10. 0 being pain does not interfere and 10 being that it completely interferes. 10 would be a worst outcome.
Baseline
Primary Pain as Assessed by Brief Pain Inventory The Brief Pain Inventory is a medical questionnaire used to measure pain, developed by the Pain Research Group of the World Health Organization Collaborating Center for Symptom Evaluation in Cancer Care.
The score is an average of seven questions about pain interference in life. The score scale is from 0 to 10. 0 being pain does not interfere and 10 being that it completely interferes. 10 would be a worst outcome.
6 weeks
Primary Pain as Assessed by Brief Pain Inventory The Brief Pain Inventory is a medical questionnaire used to measure pain, developed by the Pain Research Group of the World Health Organization Collaborating Center for Symptom Evaluation in Cancer Care.
The score is an average of seven questions about pain interference in life. The score scale is from 0 to 10. 0 being pain does not interfere and 10 being that it completely interferes. 10 would be a worst outcome.
90 days
Primary Pain as Assessed by Brief Pain Inventory The Brief Pain Inventory is a medical questionnaire used to measure pain, developed by the Pain Research Group of the World Health Organization Collaborating Center for Symptom Evaluation in Cancer Care.
The score is an average of seven questions about pain interference in life. The score scale is from 0 to 10. 0 being pain does not interfere and 10 being that it completely interferes. 10 would be a worst outcome.
6 months
Primary Overall Estimate of Functioning as Assessed by the SF-12 HRQoL Instrument (Overall HRQoL Estimate) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
Baseline
Primary Overall Estimate of Functioning as Assessed by the SF-12 HRQoL Instrument (Overall HRQoL Estimate) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
30 days
Primary Overall Estimate of Functioning as Assessed by the SF-12 HRQoL Instrument (Overall HRQoL Estimate) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
90 days
Primary Overall Estimate of Functioning as Assessed by the SF-12 HRQoL Instrument (Overall HRQoL Estimate) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
6 months
Primary Physical Functioning as Assessed by the SF-12 HRQoL Instrument Physical Component Summary (PCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
Baseline
Primary Physical Functioning as Assessed by the SF-12 HRQoL Instrument Physical Component Summary (PCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
30 days
Primary Physical Functioning as Assessed by the SF-12 HRQoL Instrument Physical Component Summary (PCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
90 days
Primary Physical Functioning as Assessed by the SF-12 HRQoL Instrument Physical Component Summary (PCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
6 months
Primary Mental/Emotional Functioning as Assessed by the SF-12 HRQoL Instrument Mental Component Summary (MCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
Baseline
Primary Mental/Emotional Functioning as Assessed by the SF-12 HRQoL Instrument Mental Component Summary (MCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
30 days
Primary Mental/Emotional Functioning as Assessed by the SF-12 HRQoL Instrument Mental Component Summary (MCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
90 days
Primary Mental/Emotional Functioning as Assessed by the SF-12 HRQoL Instrument Mental Component Summary (MCS) The short-form 12 item (SF-12) HRQoL health status instrument measures Health-Related Quality of Life (HRQoL). It produces overall HRQoL estimates as well as sub-scale scores (Physical Component Summary (PCS) and Mental Component Summary (MCS)) that assess both mental/emotional and physical functioning related to health.
The scoring scale is from 0 to 100, the higher the score the better the health related quality of life.
6 months
Secondary Number of Patients Who Will be Progressing to Ablation Therapy Progression to ablation therapy will be determined by patient preference for further intervention. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Completed NCT04758728 - Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping N/A
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Completed NCT06395025 - Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group N/A
Not yet recruiting NCT04358497 - Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome Phase 4
Completed NCT03703765 - Volume Estimation of the Limb After VEnous Treatment N/A
Completed NCT01368159 - Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein Phase 4
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Completed NCT06153680 - Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return N/A
Terminated NCT03363633 - Perforator Vein Injection for Symptomatic Venous Disease N/A
Recruiting NCT05489588 - The GORE® VIAFORT Vascular Stent Iliofemoral Study N/A
Not yet recruiting NCT06433024 - Training of a Artificial Intelligence Model to Detect Venous Diseases Using PPG Technology
Completed NCT02655887 - BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease N/A
Recruiting NCT05050799 - US Post-Market Surveillance Study of the Surfacer System
Completed NCT01993914 - Prevalence of MTHFR Polymorphisms in Venous Disease N/A
Active, not recruiting NCT04138134 - Autophagy and Venous Endothelial Function
Terminated NCT04964817 - HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study
Recruiting NCT02139085 - Great Saphenous Vein Electrocoagulation Phase 2
Completed NCT01509599 - Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation Phase 1/Phase 2